glp 1 glucose dependent insulin secretion GLP-1 receptor signalling promotes β-cell metabolism via mTOR- HIF-1α activation Targeting GLP-1, GIP & GCG

And then there's this: "A recent study came out showing about 22% developed nutritional deficiencies by one year on a GLP-1 medication," said Cohen

******Comparison based on 12-mo

Her story matters for a different reason: it shows what thoughtful medical care should look like

Originally developed for the treatment of type 2 diabetes, these peptide-based drugs are now at the forefront of both metabolic disease management and obesity treatment, driving unprecedented market growth and industry attention

If both appeal levels deny, your real options are switching to a covered alternative (phentermine, orlistat, naltrexone-bupropion) or pursuing cash-pay through a compounding provider

October 1, 2025: Most Ozempic Users Stop Taking It Within First Year of Starting, Study Finds A new study has found that most people who take Ozempic discontinue treatment within 1 year